Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Nautilus Biotechnology Inc's Business Segments
Nautilus Biotechnology Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
3
Largest Segment
Grant Revenue
Total Revenue
-
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Grant Revenue0%
- Reportable0%
- Service Revenue0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Grant Revenue | $ 0 | - |
| Reportable | $ 0 | - |
| Service Revenue | $ 0 | - |
Annual Results
Revenue Share by Reportable Segment - FY
- Grant Revenue0%
- Reportable0%
- Service Revenue0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Grant Revenue | $ 0 | - |
| Reportable | $ 0 | - |
| Service Revenue | $ 0 | - |
Description of Nautilus Biotechnology Inc
Nautilus Biotechnology Inc is a privately-held biotechnology company headquartered in South San Francisco, California. The company was founded in 2016 by a team of experienced scientists and entrepreneurs with the goal of revolutionizing the field of proteomics.
Proteomics is the study of all the proteins in a cell or organism, and it plays a crucial role in understanding various biological processes. However, traditional proteomic techniques have limitations in terms of their speed, sensitivity, and ability to analyze large-scale protein interactions. Nautilus Biotechnology aims to address these challenges by developing cutting-edge technologies that enable comprehensive and efficient protein analysis.
One of the key innovations of Nautilus is the Prism™ platform, a proprietary technology that allows for high-throughput, multiplexed protein analysis. The Prism platform combines techniques from genomics, proteomics, and computer science to provide an unprecedented level of protein characterization. It is designed to reveal detailed insights into the structure, function, and interactions of proteins, thereby enabling a deeper understanding of cellular processes and disease mechanisms.
By utilizing the Prism platform, Nautilus Biotechnology aims to accelerate drug discovery and development processes. The company believes that a more comprehensive understanding of proteins and their interactions will lead to the identification of novel drug targets and the development of more effective therapies. Their technology has the potential to significantly reduce the time and cost associated with drug discovery, making it an attractive proposition for pharmaceutical companies and researchers.
Apart from its advanced proteomics technology, Nautilus Biotechnology is also investing in bioinformatics and machine learning capabilities. The company utilizes these tools to analyze large-scale proteomic datasets and extract meaningful information that can be translated into actionable insights. This combination of innovative technology and sophisticated data analysis positions Nautilus at the forefront of next-generation proteomics research.
Nautilus Biotechnology has already attracted significant funding and support. In 2017, it raised $76 million in a Series B funding round, and the following year they secured $76 million in a Series C round. The company has also formed partnerships with leading academic institutions and pharmaceutical companies to further develop and validate its technology.
In conclusion, Nautilus Biotechnology Inc is a biotechnology company focused on revolutionizing the field of proteomics. Through its proprietary Prism platform and cutting-edge proteomic technologies, the company aims to provide comprehensive protein analysis and enable a deeper understanding of cellular processes and disease mechanisms. With its potential to accelerate drug discovery and improve therapeutic outcomes, Nautilus Biotechnology has positioned itself as a key player in the biotech industry.
Proteomics is the study of all the proteins in a cell or organism, and it plays a crucial role in understanding various biological processes. However, traditional proteomic techniques have limitations in terms of their speed, sensitivity, and ability to analyze large-scale protein interactions. Nautilus Biotechnology aims to address these challenges by developing cutting-edge technologies that enable comprehensive and efficient protein analysis.
One of the key innovations of Nautilus is the Prism™ platform, a proprietary technology that allows for high-throughput, multiplexed protein analysis. The Prism platform combines techniques from genomics, proteomics, and computer science to provide an unprecedented level of protein characterization. It is designed to reveal detailed insights into the structure, function, and interactions of proteins, thereby enabling a deeper understanding of cellular processes and disease mechanisms.
By utilizing the Prism platform, Nautilus Biotechnology aims to accelerate drug discovery and development processes. The company believes that a more comprehensive understanding of proteins and their interactions will lead to the identification of novel drug targets and the development of more effective therapies. Their technology has the potential to significantly reduce the time and cost associated with drug discovery, making it an attractive proposition for pharmaceutical companies and researchers.
Apart from its advanced proteomics technology, Nautilus Biotechnology is also investing in bioinformatics and machine learning capabilities. The company utilizes these tools to analyze large-scale proteomic datasets and extract meaningful information that can be translated into actionable insights. This combination of innovative technology and sophisticated data analysis positions Nautilus at the forefront of next-generation proteomics research.
Nautilus Biotechnology has already attracted significant funding and support. In 2017, it raised $76 million in a Series B funding round, and the following year they secured $76 million in a Series C round. The company has also formed partnerships with leading academic institutions and pharmaceutical companies to further develop and validate its technology.
In conclusion, Nautilus Biotechnology Inc is a biotechnology company focused on revolutionizing the field of proteomics. Through its proprietary Prism platform and cutting-edge proteomic technologies, the company aims to provide comprehensive protein analysis and enable a deeper understanding of cellular processes and disease mechanisms. With its potential to accelerate drug discovery and improve therapeutic outcomes, Nautilus Biotechnology has positioned itself as a key player in the biotech industry.
Nautilus Biotechnology Inc. is a company that focuses on the field of protein profiling and biomolecular analysis, providing advanced solutions to researchers and organizations in life sciences, biotechnology, and pharmaceutical industries. Their offerings can be broadly categorized into segments that encompass products and services aimed at facilitating protein analysis and enhancing biological research.
Segments
1. Research and Development
- Focuses on enhancing protein discovery and understanding protein interactions.
- Engages in partnerships and collaborations with academic institutions and research organizations to share knowledge and resources.
2. Clinical Applications
- Provides services and products targeted towards clinical research to support advancements in personalized medicine.
- Offers tools to analyze biomarkers that can aid in the diagnosis and treatment of various diseases.
3. Commercial Solutions
- Tailored services and products for pharmaceutical and biotechnology companies to streamline drug development processes.
- Offers solutions that can assist in early-stage research, preclinical studies, and clinical trials.
4. Technological Innovations
- Engages in segments that focus on novel methodologies in protein analysis, including innovative mass spectrometry techniques.
- Works on developing tools that improve sensitivity and specificity in protein measurements.
Products
1. Nautilus Proteins
- A core product line that focuses on the analysis of proteins by utilizing proprietary technologies to enhance detection and quantification.
- Offers unique approaches to protein analysis, including protein libraries and extensive databases for comparison and reference.
2. Mass Spectrometry Platforms
- Cutting-edge technology platforms that allow for advanced protein analysis.
- Facilitates the study of complex biological samples with a high level of accuracy and detail.
3. Sample Preparation Kits
- Tailored kits designed for optimal sample preparation prior to analysis, ensuring that researchers can achieve consistent and reliable results.
- Simplifies the processes involved in preparing biological samples for downstream applications.
4. Data Analysis Software
- Comprehensive software solutions that accompany their products to assist researchers in data interpretation and making sense of complex datasets.
- Provides algorithms and computational tools that enhance the usability of data generated from protein studies.
Services
1. Consultative Support
- Offers consultation services to help organizations define their protein analysis needs and choose appropriate methods and technologies.
- Provides expertise in experimental design and execution, tailored to specific research goals.
2. Custom Assay Development
- Collaborates with clients to develop bespoke assays that suit their unique biological questions and research frameworks.
- Ensures that assays are optimized for sensitivity and specificity based on the client’s requirements.
3. Training and Workshops
- Conducts training sessions and workshops on the technologies and methodologies used in protein analysis.
- Empowers researchers with knowledge and skills to effectively utilize their products and interpret data.
4. Partnership Opportunities
- Engages with various entities to create partnerships that enhance protein discovery and assist in commercialization efforts.
- Actively seeks collaborations that can lead to the development of new scientific insights and applications.
Future Directions
Nautilus Biotechnology Inc. is likely to focus on expanding its product offerings, strengthening partnerships in the life sciences community, and continuously advancing its technologies to keep pace with the growing demand for sophisticated protein analysis tools. The aim is to help accelerate discoveries that can lead to meaningful medical advancements and breakthroughs in understanding complex biological processes.
Overall, Nautilus Biotechnology Inc. strives to position itself at the forefront of protein technology, supporting both basic and applied research in various disciplines, ultimately benefiting human health and scientific progress.
Segments
1. Research and Development
- Focuses on enhancing protein discovery and understanding protein interactions.
- Engages in partnerships and collaborations with academic institutions and research organizations to share knowledge and resources.
2. Clinical Applications
- Provides services and products targeted towards clinical research to support advancements in personalized medicine.
- Offers tools to analyze biomarkers that can aid in the diagnosis and treatment of various diseases.
3. Commercial Solutions
- Tailored services and products for pharmaceutical and biotechnology companies to streamline drug development processes.
- Offers solutions that can assist in early-stage research, preclinical studies, and clinical trials.
4. Technological Innovations
- Engages in segments that focus on novel methodologies in protein analysis, including innovative mass spectrometry techniques.
- Works on developing tools that improve sensitivity and specificity in protein measurements.
Products
1. Nautilus Proteins
- A core product line that focuses on the analysis of proteins by utilizing proprietary technologies to enhance detection and quantification.
- Offers unique approaches to protein analysis, including protein libraries and extensive databases for comparison and reference.
2. Mass Spectrometry Platforms
- Cutting-edge technology platforms that allow for advanced protein analysis.
- Facilitates the study of complex biological samples with a high level of accuracy and detail.
3. Sample Preparation Kits
- Tailored kits designed for optimal sample preparation prior to analysis, ensuring that researchers can achieve consistent and reliable results.
- Simplifies the processes involved in preparing biological samples for downstream applications.
4. Data Analysis Software
- Comprehensive software solutions that accompany their products to assist researchers in data interpretation and making sense of complex datasets.
- Provides algorithms and computational tools that enhance the usability of data generated from protein studies.
Services
1. Consultative Support
- Offers consultation services to help organizations define their protein analysis needs and choose appropriate methods and technologies.
- Provides expertise in experimental design and execution, tailored to specific research goals.
2. Custom Assay Development
- Collaborates with clients to develop bespoke assays that suit their unique biological questions and research frameworks.
- Ensures that assays are optimized for sensitivity and specificity based on the client’s requirements.
3. Training and Workshops
- Conducts training sessions and workshops on the technologies and methodologies used in protein analysis.
- Empowers researchers with knowledge and skills to effectively utilize their products and interpret data.
4. Partnership Opportunities
- Engages with various entities to create partnerships that enhance protein discovery and assist in commercialization efforts.
- Actively seeks collaborations that can lead to the development of new scientific insights and applications.
Future Directions
Nautilus Biotechnology Inc. is likely to focus on expanding its product offerings, strengthening partnerships in the life sciences community, and continuously advancing its technologies to keep pace with the growing demand for sophisticated protein analysis tools. The aim is to help accelerate discoveries that can lead to meaningful medical advancements and breakthroughs in understanding complex biological processes.
Overall, Nautilus Biotechnology Inc. strives to position itself at the forefront of protein technology, supporting both basic and applied research in various disciplines, ultimately benefiting human health and scientific progress.